Evan Edwards is Vice-President of Product Development at kaléo Inc., a pharmaceutical company devoted to developing innovative drug delivery technologies. He is co-founder of kaléo, formerly Intelliject, Inc., and is co-inventor of the company’s technology platforms. Kaléo’s first product, Auvi-Q®, a novel epinephrine auto-injector was launched in 2013 by Sanofi, their commercial partner for the product in the US and Canada. Evan manages all areas of the invention and design process, including the company’s intellectual property portfolio where he is named on over 140 patents issued and pending domestically and abroad.
Evan has been recognized among his peers for his expertise and work in human factors engineering (HFE) and, in particular, the application of human factors to the Design Control process. He is actively involved with both the Human Factors & Ergonomics Society (HFES) and the National Collegiate Inventors and Innovators Alliance (NCIIA). In addition, Evan serves on the Medical Devices for Injection and Human Factors Committees for the Association of the Advancement of Medical Instrumentation (AAMI).
Evan is a graduate of the University of Virginia where he earned a B.S. in Mechanical Engineering and a M.S. in Systems Engineering with a concentration on HFE. In 2012 he was named among MDDI’s “40 Medtech Innovators Under 40”.